Skip navigation

Network Meeting Cambridge: Biosimilars - a protein-engineered biotech trend for the future?

17:30 - 20:30

Location:
Cambridge Airport, Newmarket Road, Cambridge CB5 8RX
Date:
25 March 2015
 

In an evolution of our Networking Meetings aimed at meeting the need to bring leading edge scientists together with industry experts and collaborators in order to enhance the translational research interface, this event will be a game of two halves. A scientific session will update attendees on what’s in the pipeline for next generation biologics and followed by a session covering recent approvals and pitfalls in the commercial success of biosimilars and Q&A about the future opportunities for this region.

Programme:
 
16.15  Delegate registration and networking
 
16.45  Welcome from the Host and Chair               
 
17.00  Minimising Therapeutic Antibody Immunogenicity
   Dr Matthew Baker, CSO, Abzena 
 
17.30  Commercial Considerations for Biosimilar Developers
           Sahar Shepperd, Associate, Bristows LLP
   *Click to view the presentation
 
17.40  Regulatory and Legal Considerations Relating to Biosimilars
           Dominic Adair, Partner, Bristows LLP
   *Click to view the presentation
 
18.00  Refreshments and Terminal Tour
 
18.30  Q&A Discussion: What Does the Rise of Biosimilars Mean for the Biotech Industry? 
 
19.30  Closing remarks from the Chair
 
19.35  Networking over drinks and canapes
 
20.30  Close


Prices:
Gold Member 3 free delegates then £40.00 + VAT for additional delegates
Silver Member 3 free delegates then £40.00 + VAT for additional delegates
Academia Contact Nadia on nadia@onenucleus.com for free registration
Non-member £150 + VAT
Title: Network Meeting Cambridge: Biosimilars - a protein-engineered biotech trend for the future?
Start: 2015-03-25 17:30:00Z
End: 2015-03-25 20:30:00Z